Biosignatures for Depression: Advances in Precision Medicine

Grand Rounds

Event Info

Breadcrumb

  1. Events
  2. Grand Rounds
  3. Biosignatures for Depression: Advances in Precision Med...

Biosignatures for Depression: Advances in Precision Medicine


14September

Event Info
Category Date and Time
  • Wednesday, September 14, 2022
  • 01:00 PM - 02:00 PM
Topic and Speaker
  • Biosignatures for Depression: Advances in Precision Medicine
  • Madhukar H. Trivedi MD
    • Betty Jo Hay Distinguished Chair in Mental Health
    • Julie K. Hersh Chair for Depression Research and Clinical Care
    • University of Texas Southwestern Medical Center
    Madhukar H. Trivedi

Location Event Coordinator
  • Department of Psychiatry Education Team
  • psych-education [at] uic.edu
Video Recording
Event Details

Madhukar Trivedi, M.D., is a Professor of Psychiatry, Chief of the Division of Mood Disorders, and founding Director of the Center for Depression Research and Clinical Care at UT Southwestern Medical Center, where he holds the Betty Ho Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care. Certified by the American Board of Psychiatry and Neurology, Dr. Trivedi focuses on developing and validating biosignatures of depression. He also conducts research on pharmacological, psychosocial, and nonpharmacological treatments for depression. He has been a principal investigator on numerous translational research projects and clinical trials. He serves on the editorial board of CNS Spectrums, Clinical Medicine: Psychiatry, Journal of Clinical Psychiatry, Journal of Affective Disorders, Psychiatric Annals and Asian Journal of Psychiatry. He is a member of numerous other organizations, including the The American Brain Coalition, American College of Neuropsychopharmacology, American College of Psychiatrists, American Medical Association, American Psychiatric Association, Dallas County Medical Society, Society of Biological Psychiatry, Texas Medical Association, and the Texas Society of Psychiatric Physicians. Named a Texas Monthly Super Doctor multiple times, he has received numerous accolades, including the Gerald L. Klerman Award from the National Depressive and Manic-Depressive Association Scientific Advisory Board, the Psychiatric Excellence Award from the Texas Society of Psychiatric Physicians, the Gerald Klerman Senior Investigator Award, the American Psychiatric Association Award for Research, and the Mood Disorders Research Award from the American College of Psychiatrists. Dr. Trivedi was listed by Thomson Reuters’ World’s Most Influential Scientific Minds as one of the nation’s most highly cited researchers in psychiatry six years in a row.


Audience:

Psychiatrists, Neurologists, and other affiliated professionals interested in mental health

Purpose:

To provide current information on research, treatment, and policy issues relating to psychiatry and its adjunct fields

Instructional level:

Advanced

Objectives:

  1. Identify brain- and blood-based biomarkers of antidepressant response
  2. Apply data-driven approaches to develop precision medicine for depression
  3. Assess the direction of biomarker research in psychiatry

The University of Illinois at Chicago (UIC) College of Medicine is accredited by the Accreditation Council for Continuing Medical Education ACCME) to provide continuing medical education for physicians.

The University of Illinois at Chicago (UIC) College of Medicine designates this live activity for a maximum of 1credit AMA PRA Category 1 credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education Units (1) will be available for Social Workers and affiliated reciprocal agencies. Illinois Board License number 159-000112.

The Department of Psychiatry at the University of Illinois at Chicago is approved by the American Psychological Association to sponsor continuing education for psychologists.  The Department of Psychiatry at the University of Illinois at Chicago maintains responsibility for this program and its content. This event is 1 credit hour continuing education.

No member of the planning committee for this activity have reported a relevant relationship with a commercial interest.  There is no conflict of interest and nothing to disclose.

Dr. Trivedi has disclosed providing consulting services for the following companies: Acadia Pharmaceuticals Inc, Alkermes Inc, Axsome Therapeutics, Biogen MA Inc., Cerebral Inc., Circular Genomics Inc, Compass Pathfinder Limited, GH Research Limited, Heading Health Inc, Janssen, Legion Health Inc, Merck Sharp & Dohme Corp., Mind Medicine (MindMed) Inc, Merck Sharp & Dhome LLC, Neurocrine Biosciences Inc, Noema Pharma AG, Orexo US Inc, Otsuka American Pharmaceutical Inc, Otsuka Canada Pharmaceutical Inc, Otsuka Pharmaceutical Development & Commercialization Inc, Praxis Precision Medicines Inc, SAGE Therapeutics, Sparian Biosciences Inc, Takeda Pharmaceutical Company Ltd, Titan Pharmaceuticals Inc, WebMD; serving as a scientific advisor to the following companies: Alto Neuroscience Inc, Compass Pathfinder Limited, Heading Health, GreenLight VitalSign6 Inc, Legion Health Inc, Merck Sharp & Dohme Corp, Orexo US Inc, Signant Health; and owning stock in the following companies: Alto Neuroscience Inc, Circular Genomics Inc, GreenLight VitalSign6 Inc, Legion Health Inc.